Glargine and Lispro - Two cases of mistaken identity

被引：6

作者：

Adlersberg, MA ^{[1
]}

Fernando, S ^{[1
]}

Spollett, GR ^{[1
]}

Inzucchi, SE ^{[1
]}

机构：

[1] Yale Univ, Sch Med, Endocrinol Sect, Dept Med, New Haven, CT 06520 USA

来源：

DIABETES CARE | 2002年 / 25卷 / 02期

关键词：

D O I：

10.2337/diacare.25.2.404

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：404 / 405

页数：2

共 5 条

[1] Insulin glargine [J].

Gillies, PS ;

Figgitt, DP ;

Lamb, HM .

DRUGS, 2000, 59 (02) :253-260

[2] Pharmacokinetics and pharmacodynamics of subcutaneous injection of long-acting human insulin analog glargine, NPH insulin, and ultralente human insulin and continuous subcutaneous infusion of insulin lispro [J].

Lepore, M ;

Pampanelli, S ;

Fanelli, C ;

Porcellati, F ;

Bartocci, L ;

Di Vincenzo, A ;

Cordoni, C ;

Costa, E ;

Brunetti, P ;

Bolli, GB .

DIABETES, 2000, 49 (12) :2142-2148

[3] Less hypoglycemia with insulin glargine in intensive insulin therapy for the 1 diabetes [J].

Ratner, RE ;

Hirsch, IB ;

Neifing, JL ;

Garg, SK ;

Mecca, TE ;

Wilson, CA .

DIABETES CARE, 2000, 23 (05) :639-643

[4] Basal insulin glargine (HOE 901) versus NPH insulin in patients with type 1 diabetes on multiple daily insulin regimens [J].

Rosenstock, J ;

Park, G ;

Zimmerman, J .

DIABETES CARE, 2000, 23 (08) :1137-1142

[5] Less nocturnal hypoglycemia and better post-dinner glucose control with bedtime insulin glargine compared with bedtime NPH insulin during insulin combination therapy in type 1 diabetes [J].

Yki-Järvinen, H ;

Dressler, A ;

Ziemen, M .

DIABETES CARE, 2000, 23 (08) :1130-1136

← 1 →